Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Diabetes Mellitus, Insulin-Dependent, 12
×
90 days
×
Clear all
Filters
3
NCT07000149
2026-03-10
eVOLVE-RCC02
AstraZeneca
Phase 3
Active not recruiting
1,116 enrolled
NCT01843374
2026-03-05
Tremelimumab
MedImmune LLC
Phase 2
Active not recruiting
571 enrolled
19 charts